Compile Data Set for Download or QSAR
maximum 50k data
Found 285 Enz. Inhib. hit(s) with all data for entry = 10634
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555833(1-[(3S,5R)-5-(methoxymethyl)-1-(prop-2-enoyl)pyrro...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555834((S)-1-(1-acryloylpyrrolidin-3-yl)-3-((2-methyl-1H-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555835(3-[2-(1-ethyl-2-methyl-1,3-benzodiazol-5-yl)ethyny...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555836(1-[(3S,5R)-5-(methoxymethyl)-1-(prop-2-enoyl)pyrro...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555837(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555838(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555839((S)-1-(1-acryloylpyrrolidin-3-yl)-3-((1,2-dimethyl...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555840(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555842(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555843(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555844(1-((3S,5R)-1-acryloyl-5- methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555845(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555846(1-((3S,5R)-1-acryloyl-5-methoxymethyl)pyrrolidin-3...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555847(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555848(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555849(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555850(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555851(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555852(1-((3S,5R)-1-acryloyl-5-(pethoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555853(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555854(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555855(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555857(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555859(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555860(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555861(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555862(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555863(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555864(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555865(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555866(1-((3S,5S)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555867(1-((3S,5R)-1-acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555869(3-[2-(1-ethyl-6-fluoro-2-methyl-1,3-benzodiazol-5-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555870(3-[2-(4-chloro-1-ethyl-2-methyl-1,3-benzodiazol-5-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555872(3-[2-(6-fluoro-1-methyl-1,3-benzodiazol-5-yl)ethyn...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555874(3-[2-(2-cyclopropyl-1H-1,3-benzodiazol-5-yl)ethyny...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555875(3-[2-(2-cyclopropyl-1-methyl-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555876(1-[(3S,5R)-5-(methoxymethyl)-1- (prop-2-enoyl)pyrr...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555877(3-[2-(2-cyclopropyl-1-ethyl-4,6-difluoro-1,3-benzo...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555878(3-[2-[4,6-difluoro-2-(trifluoromethyl)-1H-1,3-benz...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555879(3-[2-[1-(difluoromethyl)-4,6-difluoro-2-methyl-1,3...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555881(3-[2-(2-Amino-1-methyl-1,3-benzodiazol-5-yl)ethyny...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555882(3-[2-(2-Cyclopropyl-4,6-difluoro-1-methyl-1,3-benz...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555883(1-((3S,5S)-1-Acryoyl-5-(methoxymethyl)pyrrolidin-3...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555884(1-[(3S,5R)-5-(Methoxymethyl)-1-(prop-2-enoyl)pyrro...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555886(1-((3S,5R)-1-Acryloyl-5-(methoxymethyl)pyrrolidin-...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555888(1-[(3S,5R)-5-(Methoxymethyl)-1-(prop-2-enoyl)pyrro...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555891(3-[2-(1-Tert-butyl-1,3-benzodiazol-5-yl)ethynyl]-1...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555892(3-[2-[2-(Dimethylamino)-1-methyl-1,3-benzodiazol-5...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFibroblast growth factor receptor 2(Homo sapiens (Human))
Kinnate Biopharma

US Patent
LigandPNGBDBM555893(3-[2-(2-Cyclopropyl-4,6-difluoro-1H-1,3-benzodiazo...)
Affinity DataIC50: <100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 285 total ) | Next | Last >>
Jump to: